The antitumor efficiency of combined electrochemotherapy and single dose irradiation on a breast cancer tumor model

Radiology and Oncology

Volumn 46, Issue 3, 2012, Pages 226-232

  Raeisi, Elham ^a,b   Aghamiri, Seyed ^b   Bandi, Azin ^c   Rahmatpour, Negar ^c   Firoozabadi, Seyed ^a   Kafi Abad, Sedigheh ^d   Mir, Lluis ^e,f,g  

^a TARBIAT MODARES UNIVERSITY   (Iran)

^b UNIVERSITY OF GENEVA   (Switzerland)

^c SHAHID BEHESHTI UNIVERSITY   (Iran)

^d IRANIAN BLOOD TRANSFUSION ORGANIZATION   (Iran)

^e CNRS   (France)

^f UNIVERSITÉ PARIS SACLAY   (France)

^g INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

cisplatin; electroporation; invasive ductal carcinoma; irradiation; multimodalities

Indexed keywords

CISPLATIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CARCINOMA; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER THERAPY; COBALT THERAPY; CONTROLLED STUDY; ELECTROCHEMOTHERAPY; FEMALE; GAMMA RADIATION; IRRADIATION; MOUSE; MULTIMODALITY CANCER THERAPY; NONHUMAN; RADIATION DOSE; RADIOSENSITIZATION; TUMOR GROWTH; TUMOR MODEL; TUMOR VOLUME;

EID: 84867305071     PISSN: 13182099     EISSN: 15813207     Source Type: Journal    
DOI: 10.2478/v10019-012-0035-x     Document Type: Article

References (35)

1. Gately DP, Howell SB. Cellular accumulation of the anticancer agent CDDP: a review. Br J Cancer 1993; 67: 1171-6. (Pubitemid 23172848)
2. Kelland L. The resurgence of platinum-based cancer chemotherapy. Nat Rev Cancer 2007; 7: 573-84. (Pubitemid 47106628)
3. Lekic M, Kovac V, Triller N, Knez L, Sadikov A, Cufer T. Outcome of small cell lung cancer (SCLC) patients with brain metastases in a routine clinical setting. Radiol Oncol 2012; 46(3): 226-232.; 46: 54-9.
4. Malecki K, Glinski B, Mucha-Malecka A, Rys J, Kruczak A, Roszkowski K, et al. Prognostic and predictive significance of p53, EGFr, Ki-67 in larynx preservation treatment. Rep Pract Oncol Radiother. 2010; 15: 87-92.
5. Kovac V, Smrdel U. Meta-analyses of clinical trials in patients with non-small cell lung cancer. Neoplasma 2004; 51: 334-40. (Pubitemid 39486105)
6. Erculj N, Kovac V, Hmeljak J, Dolzan V. The influence of platinum pathway polymorphisms on the outcome in patients with malignant mesothelioma. Ann Oncol 2012; 23: 961-7.
7. Kelland LR. Preclinical perspectives on platinum resistance. Drugs 2000; 59: 1-8. (Pubitemid 30344986)
8. Begg AC, Deurloo MJ, Kop W, Bartelink H. Improvement of combined modality therapy with CDDP and radiation using intratumoral drug administration in murine tumors. Radiother Oncol 1994; 31: 129-37. (Pubitemid 24189088)
9. Sharma VM, Wilson WR. Radiosensitization of advanced squamous cell carcinoma of the head and neck with CDDP during concomitant radiation therapy. Eur Arch Otorhinolaryngol 1999; 256: 462-5. (Pubitemid 29516188)
10. Bergs JWJ, Franken NAP, Cate RT, Bree CV, Haveman J. Effects of CDDP and γ-irradiation on cell survival, the induction of chromosomal aberrations and apoptosis in SW-1573 cells. Mutat Res 2006; 594: 148-54. (Pubitemid 43170994)
11. Ning S, Yu N, Brown DM, Kanekal S, Knox SJ. Radiosensitization by intratumoral administration of CDDP in a sustained-release drug delivery system. Radiother Oncol 1999; 50: 215-23. (Pubitemid 29155548)
12. Strojan P, Katarina K, Lojze S, Erika S, Igor F, Boris J, Aleksandar A, Marjan B, Branko Z. Concomitant chemoradiotherapy with Mitomycin C and Cisplatin in advanced unresectable carcinoma of the head and neck: Phase I-II Clinical Study. Int J Radiat Oncol Biol Phys 2008; 72: 365-72.
13. Carde P, Laval F. Effect of cis-dichlorodiammineplatinum (II) and X-rays on mammalian cell survival. Int J Radiat Oncol Biol Phys 1981; 7: 929-33. (Pubitemid 11017324)
14. Geldof AA, Slotman BJ. Radiosensitizing effect of CDDP in prostate cancer cell lines. Cancer Lett 1996; 101: 233-9. (Pubitemid 26082279)
15. Melvik JE, Pettersen EO, Gordon PB, Seglen PO. Increase in cis-dichlorodiammineplatinum (II) cytotoxicity upon reversible electro-permeabilization of the plasma membrane in cultured human NHIK 3025 cells. Eur J Cancer Clin Oncol 1986; 22: 1523-30. (Pubitemid 17228773)
16. Cemazar M, Miklavcic D, Vodovnik L, Jarm T, Rudolf Z, Stabuc B, et al. Improved therapeutic effect of electrochemotherapy with cisplatin by intratumoral drug administration and changing of electrode orientation for electromeatabilization on EAT tumor model in mice. Radiol Oncol 1995; 29: 121-7.
17. Sersa G, Cemazar M, Miklavcic D. Antitumor effectiveness of electrochemotherapy with cis-diamminedichloroplatinum (II) in mice. Cancer Res 1995; 55: 3450-5.
18. Sersa G, Cemazar M, Semrov D, Miklavcic D. Changing electrode orientation improves the efficacy of electrochemotherapy of solid tumors in mice. Bioelectrochem Bioenerg 1996; 39: 61-6. (Pubitemid 26050126)
19. Mir LM, Orlowski S. The basis of electrochemotherapy. In: Jaroszeski MJ, Heller R, Gilbert R, editors. Electrochemotherapy, Electrogentherapy, and Transdermal Drug Delivery. Electrically Mediated Delivery of Molecules to Cells. Totowa: Humana Press; 2000. p. 99-117.
20. Silve A, Mir LM. Clinical aspects of electroporation. In: Kee ST, Gehl J, Lee EW, editors. Cell electropermeabilization and cellular uptake of small molecules: the ECT concept. New York; Springer; 2011. p. 69-82.
21. Mir LM, Orlowski S, Belehradek J Jr, Paoletti C. Electrochemotherapy potentiation of antitumor effect of bleomycin by local electric pulses. Eur J Cancer 1991; 27: 68-72.
22. Marty M, Sersa G, Garbay JR, Gehl J, Collins CG, Snoj M, et al. Electrochemotherapy-an easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) study. EJC Suppl 2006; 4: 3-13. (Pubitemid 44755131)
23. Sersa G, Stabuc B, Cemazar M, Jancar B, Miklavcic D, Rudolf Z. Electrochemotherapy with CDDP: potentiation of local CDDP antitumor effectiveness by application of electric pulses in cancer patients. Eur J Cancer 1998; 34: 1213-8. (Pubitemid 28342112)
24. Cemazar M, Sersa G, Miklavcic D, Scancar J, Dolzan, Golouh R, et al . Increased platinum accumulation in SA-1 tumor cells after in vivo electrochemotherapy with CDDP. Br J Cancer 1999; 79: 1386-91. (Pubitemid 29116794)
25. Sersa G, Stabuc B, Cemazar M, Miklavcic D, Rudolf Z. Electrochemotherapy with cisplatin: clinical experience in malignant melanoma patients. Clin Cancer Res 2000; 6: 863-7. (Pubitemid 30159341)
26. Jarm T, Cemazar M, Miklavcic D, Sersa G. Antivascular effects of electrochemotherapy: implications in treatment of bleeding metastases. Expert Rev Anticancer Ther 2010; 10: 729-46.
27. Sersa G, Kranjc S, Cemazar M. Improvement of combined modality therapy with CDDP and radiation using electroporation of tumors. Int J Radiat Oncol Biol Phys 2000; 46: 1037-41. (Pubitemid 30114418)
28. Kranjc S, Cemazar M, Grosel A, Scancar J, Sersa G. Electroporation of LPB sarcoma cells in vitro and tumors in vivo increases the radiosensitizing effect of CDDP. Anticancer Res 2003; 23: 275-82.
29. Kranjc S, Cemazar M, Grosel A, Pipan Z, Sersa G. Effect of electroporation on radiosensitization with cisplatin in two cell lines with different chemo-and radiosensitivity. Radio Oncol 2003; 37: 101-7.
30. Hassan ZM, Yaraee R, Chazanfari T, Safar Kejad AH, Nozari B. Immunomodulatory affect of R10 fraction of garlic extract on natural killer activity. Int J Immunopharmaco 2003; 3: 1483-9. (Pubitemid 37025729)
31. Raeisi E, Firoozabadi SMP, Hajizadeh S, Rajabi H, Hassan Z M. The effect of high-frequency electric pulses on tumor blood flow in vivo. J Membrane Biol 2010; 236: 163-66.
32. Kranjc S, Tevz G, Vidic S, Cemazar M, Sersa G. Radiosensitizing effect of electrochemotherapy in a fractionated radiation regimen in radiosensitive murine sarcoma and radioresistant adenocarcinoma tumor model. Radiat Res 2009; 172: 677-85.
33. Sersa G, Kranjc S, Cemazar M. Advanced electroporation techniques in biology and medicine. In: Pakhomov A, Miklavcic D, Marko MS, editors. Combined modality therapy: electrochemotherapy with tumor irradiation. CRC Press; 2010. p. 441-452.
34. Sersa G, Cemazar M, Rudolf Z, Fras AP. Adenocarcinoma skin metastases treated by electrochemotherapy with cisplatin combined with radiation. Radiol Oncol 1999; 33: 291-6. (Pubitemid 30019984)
35. Skarlatos I, Kyrgias G, Mosa E, Provatopoulou X, Spyrou M, Theodorou K, et al. Electrochemotherapy in cancer patients: first clinical trial in Greece. In Vivo 2011; 25: 265-74.